withaferin-a has been researched along with Weight-Gain* in 2 studies
1 trial(s) available for withaferin-a and Weight-Gain
Article | Year |
---|---|
Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial.
Chronic stress has been associated with a number of illnesses, including obesity. Ashwagandha is a well-known adaptogen and known for reducing stress and anxiety in humans. The objective of this study was to evaluate the safety and efficacy of a standardized root extract of Ashwagandha through a double-blind, randomized, placebo-controlled trial. A total of 52 subjects under chronic stress received either Ashwagandha (300 mg) or placebo twice daily. Primary efficacy measures were Perceived Stress Scale and Food Cravings Questionnaire. Secondary efficacy measures were Oxford Happiness Questionnaire, Three-Factor Eating Questionnaire, serum cortisol, body weight, and body mass index. Each subject was assessed at the start and at 4 and 8 weeks. The treatment with Ashwagandha resulted in significant improvements in primary and secondary measures. Also, the extract was found to be safe and tolerable. The outcome of this study suggests that Ashwagandha root extract can be used for body weight management in adults under chronic stress. Topics: Adult; Body Weight; Chronic Disease; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Phytotherapy; Plant Extracts; Stress, Psychological; Weight Gain; Young Adult | 2017 |
1 other study(ies) available for withaferin-a and Weight-Gain
Article | Year |
---|---|
Subacute toxicity study of the combination of ginseng (Panax ginseng) and ashwagandha (Withania somnifera) in rats: a safety assessment.
Ginseng (Panax ginseng) and Ashwagandha (Withania somnifera) are widely used as geriatric tonics. Both individually have not shown any toxicity on long term administration. Study was planned to assess the safety of the combination by doing subacute toxicity study in rats with 90 days oral administration using three doses. Food consumption, body weight, haematological, biochemical and histopathological parameters were studied. There was significant increase in body weight, food consumption and liver weight, and improved hematopoiesis was observed. Brain, heart, lung, liver, spleen, kidneys, stomach, testis and ovaries were normal on gross examination and histopathologically. Subacute toxicity studies in rats did not reveal any toxicity. Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Eating; Female; Hemoglobins; Liver; Male; Organ Size; Panax; Plant Extracts; Plants, Medicinal; Rats; Weight Gain; Withania | 1998 |